Chapter 10: Pharmacology

Pharmacology integrates multiple scientific disciplines to examine how chemical substances interact with living organisms and produce therapeutic or harmful effects. The field divides into complementary branches that collectively inform safe and effective drug use: pharmacodynamics investigates the mechanisms by which drugs produce their effects on body tissues and systems, while pharmacokinetics traces the quantitative journey of drugs through the body including absorption across membranes, distribution to target sites, metabolic transformation, and ultimate elimination. Pharmacotherapeutics applies this knowledge to select and administer appropriate medications for specific clinical conditions, whereas toxicology examines the adverse consequences of substance exposure across varying timeframes from acute to chronic. Drug administration routes significantly influence how and where medications reach therapeutic targets; enteral routes utilize the digestive system whereas parenteral routes bypass it entirely through injections, inhalation, or transdermal application. Critical factors governing drug movement include membrane permeability based on lipid solubility, surface area available for absorption, blood flow distribution, and anatomical barriers like the blood-brain barrier that restrict access to certain tissues. The liver accomplishes biotransformation through enzymatic Phase I and Phase II reactions that convert lipid-soluble compounds into water-soluble metabolites for renal elimination, occasionally activating inactive prodrugs in the process. Kidney function determines drug clearance via glomerular filtration, tubular reabsorption, and active secretion. Quantifying drug action requires understanding dose-response relationships, time-response patterns, the therapeutic index comparing lethal to effective doses, and parameters such as onset time, peak effect, and duration of action. Individual patient responses vary based on age, disease states particularly hepatic or renal dysfunction, and the first-pass effect where initial hepatic metabolism reduces systemic drug availability. Regulatory frameworks including the Pure Food and Drug Act, Federal Food, Drug and Cosmetic Act, and Controlled Substances Act establish mandatory preclinical testing and multi-phase clinical trials ensuring new medications demonstrate safety and efficacy before market approval.